Surface modification of graphite encapsulated iron nanoparticles by plasma processing☆

The graphite encapsulated iron nanoparticles were fabricated by using arc dischargemethod. The synthesized nanoparticles were pre-treated by an inductively-coupled RF Ar plasma and then post-treated by NH3 plasma under various gas pressures and treatment times. Analyses of XPS spectra have been carried out to study the effect of the plasma treatment on the surface modification of nitrogen-containing groups. The morphological changes of the particles surface by plasma treatment have also been analyzed by using HR-TEM. Present results show that the highest values of N/C atomic ratio of 5.4 % is obtained by applying 10 min of Ar plasma pre-treatment and 2 min of NH3 plasma post-treatment conducted in RF power of 80W and gas pressure of 50 Pa

Sol-gel chemistry mediated Zn/Al-based complex dispersant for SWCNT in water without foam formation

We report a bimetallic Zn/Al complex as an efficient inorganic dispersant for SWCNT, synthesized from Zn(CH3COO)(2) and Al(NO3)(3). The Zn/Al complex shows more than four times greater efficiency at dispersing SWCNT than widely used surfactants (CTAB and SDS). Besides remarkable dispersibility, the Zn/Al complex does not foam upon any shaking treatment and it can be used just after quick dissolution of the powdered form, which is a marked advantage over surfactants. The Zn/Al complex, containing amorphous Al(CH3COO)(3) and a complex of Zn2+ and NO3- ions, should have a unique dispersion mechanism, differing from the surfactants. Al(CH3COO)(3) has higher affinity for SWCNT than ions, adsorbing onto its surface in the first layer and attracting Zn2+ and NO3- ions. Charge transfer interactions between the Zn/Al complex and SWCNT, as evidenced by optical absorption spectroscopy, should induce a charge on SWCNT; the zeta potential of such coated SWCNT was +55 mV, indicating a high dispersion stability in aqueous media. Hence, the Zn/Al complex can widen the applications of SWCNT to various technologies such as the transparent and conductive films, as well as high performance composite polymers. (C) 2015 Elsevier Ltd. All rights reserved.ArticleCARBON. 94:518-523 (2015)journal articl

Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study

[Background] Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrotic lung disease that leads to respiratory failure and death. Although there is a greater understanding of the etiology of this disease, accurately predicting the disease course in individual patients is still not possible. This study aimed to evaluate serum cytokines/chemokines as potential biomarkers that can predict outcomes in IPF patients. [Methods] A multi-institutional prospective two-stage discovery and validation design using two independent cohorts was adopted. For the discovery analysis, serum samples from 100 IPF patients and 32 healthy controls were examined using an unbiased, multiplex immunoassay of 48 cytokines/chemokines. The serum cytokine/chemokine values were compared between IPF patients and controls; the association between multiplex measurements and survival time was evaluated in IPF patients. In the validation analysis, the cytokines/chemokines identified in the discovery analysis were examined in serum samples from another 81 IPF patients to verify the ability of these cytokines/chemokines to predict survival. Immunohistochemical assessment of IPF-derived lung samples was also performed to determine where this novel biomarker is expressed. [Results] In the discovery cohort, 18 cytokines/chemokines were significantly elevated in sera from IPF patients compared with those from controls. Interleukin-1 receptor alpha (IL-1Rα), interleukin-8 (IL-8), macrophage inflammatory protein 1 alpha (MIP-1α), and cutaneous T-cell-attracting chemokine (CTACK) were associated with survival: IL-1Rα, hazard ratio (HR) = 1.04 per 10 units, 95% confidence interval (95% CI) 1.01–1.07; IL-8, HR = 1.04, 95% CI 1.01–1.08; MIP-1α, HR = 1.19, 95% CI 1.00–1.36; and CTACK, HR = 1.12 per 100 units, 95% CI 1.02–1.21. A replication analysis was performed only for CTACK because others were previously reported to be potential biomarkers of interstitial lung diseases. In the validation cohort, CTACK was associated with survival: HR = 1.14 per 100 units, 95% CI 1.01–1.28. Immunohistochemistry revealed the expression of CTACK and CC chemokine receptor 10 (a ligand of CTACK) in airway and type II alveolar epithelial cells of IPF patients but not in those of controls. [Conclusions] CTACK is a novel prognostic biomarker of IPF

Sol–gel chemistry mediated Zn/Al-based complex dispersant for SWCNT in water without foam formation

We report a bimetallic Zn/Al complex as an efficient inorganic dispersant for SWCNT, synthesized from Zn(CH3COO)(2) and Al(NO3)(3). The Zn/Al complex shows more than four times greater efficiency at dispersing SWCNT than widely used surfactants (CTAB and SDS). Besides remarkable dispersibility, the Zn/Al complex does not foam upon any shaking treatment and it can be used just after quick dissolution of the powdered form, which is a marked advantage over surfactants. The Zn/Al complex, containing amorphous Al(CH3COO)(3) and a complex of Zn2+ and NO3- ions, should have a unique dispersion mechanism, differing from the surfactants. Al(CH3COO)(3) has higher affinity for SWCNT than ions, adsorbing onto its surface in the first layer and attracting Zn2+ and NO3- ions. Charge transfer interactions between the Zn/Al complex and SWCNT, as evidenced by optical absorption spectroscopy, should induce a charge on SWCNT; the zeta potential of such coated SWCNT was +55 mV, indicating a high dispersion stability in aqueous media. Hence, the Zn/Al complex can widen the applications of SWCNT to various technologies such as the transparent and conductive films, as well as high performance composite polymers. (C) 2015 Elsevier Ltd. All rights reserved.ArticleCARBON. 94:518-523 (2015)journal articl

Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

BACKGROUND: Intravascular ultrasound (IVUS) was only rarely used in landmark trials comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in patients with multivessel disease. OBJECTIVES: The authors aimed to evaluate clinical outcomes after optimal IVUS-guided PCI in patients undergoing multivessel PCI. METHODS: The OPTIVUS (OPTimal IntraVascular UltraSound)-Complex PCI study multivessel cohort was a prospective multicenter single-arm study enrolling 1, 021 patients undergoing multivessel PCI, including left anterior descending coronary artery using IVUS, aiming to meet the prespecified criteria (OPTIVUS criteria: minimum stent area > distal reference lumen area [stent length ≥28mm], and minimum stent area >0.8 × average reference lumen area [stent length <28mm]) for optimal stent expansion. The primary endpoint was major adverse cardiac and cerebrovascular events (MACCE) (death/myocardial infarction/stroke/any coronary revascularization). The predefined performance goals were derived from the CREDO-Kyoto (Coronary REvascularization Demonstrating Outcome study in Kyoto) PCI/CABG registry cohort-2 fulfilling the inclusion criteria in this study. RESULTS: In this study, 40.1% of the patients met OPTIVUS criteria in all stented lesions. The cumulative 1-year incidence of the primary endpoint was 10.3% (95% CI: 8.4%-12.2%), which was significantly lower than the predefined PCI performance goal of 27.5% (P < 0.001), and which was numerically lower than the predefined CABG performance goal of 13.8%. The cumulative 1-year incidence of the primary endpoint was not significantly different regardless of meeting or not meeting OPTIVUS criteria. CONCLUSIONS: Contemporary PCI practice conducted in the OPTIVUS-Complex PCI study multivessel cohort was associated with a significantly lower MACCE rate than the predefined PCI performance goal, and with a numerically lower MACCE rate than the predefined CABG performance goal at 1 year

Fully gapped superconductivity with no sign change in the prototypical heavy-fermion CeCu2Si2

In exotic superconductors including high-$T_c$ copper-oxides, the interactions mediating electron Cooper-pairing are widely considered to have a magnetic rather than the conventional electron-phonon origin. Interest in such exotic pairing was initiated by the 1979 discovery of heavy-fermion superconductivity in CeCu$_2$Si$_2$, which exhibits strong antiferromagnetic fluctuations. A hallmark of unconventional pairing by anisotropic repulsive interactions is that the superconducting energy gap changes sign as a function of the electron momentum, often leading to nodes where the gap goes to zero. Here, we report low-temperature specific heat, thermal conductivity and magnetic penetration depth measurements in CeCu$_2$Si$_2$, demonstrating the absence of gap nodes at any point on the Fermi surface. Moreover, electron-irradiation experiments reveal that the superconductivity survives even when the electron mean free path becomes substantially shorter than the superconducting coherence length. This indicates that superconductivity is robust against impurities, implying that there is no sign change in the gap function. These results show that, contrary to long-standing belief, heavy electrons with extremely strong Coulomb repulsions can condense into a fully-gapped s-wave superconducting state, which has an on-site attractive pairing interaction.Comment: 8 pages, 5 figures + Supplement (3 pages, 5 figures

DOCK2 is involved in the host genetics and biology of severe COVID-19

「コロナ制圧タスクフォース」COVID-19疾患感受性遺伝子DOCK2の重症化機序を解明 --アジア最大のバイオレポジトリーでCOVID-19の治療標的を発見--. 京都大学プレスリリース. 2022-08-10.Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2, 393 cases of COVID-19 in a cohort of Japanese individuals collected during the initial waves of the pandemic, with 3, 289 unaffected controls. We identified a variant on chromosome 5 at 5q35 (rs60200309-A), close to the dedicator of cytokinesis 2 gene (DOCK2), which was associated with severe COVID-19 in patients less than 65 years of age. This risk allele was prevalent in East Asian individuals but rare in Europeans, highlighting the value of genome-wide association studies in non-European populations. RNA-sequencing analysis of 473 bulk peripheral blood samples identified decreased expression of DOCK2 associated with the risk allele in these younger patients. DOCK2 expression was suppressed in patients with severe cases of COVID-19. Single-cell RNA-sequencing analysis (n = 61 individuals) identified cell-type-specific downregulation of DOCK2 and a COVID-19-specific decreasing effect of the risk allele on DOCK2 expression in non-classical monocytes. Immunohistochemistry of lung specimens from patients with severe COVID-19 pneumonia showed suppressed DOCK2 expression. Moreover, inhibition of DOCK2 function with CPYPP increased the severity of pneumonia in a Syrian hamster model of SARS-CoV-2 infection, characterized by weight loss, lung oedema, enhanced viral loads, impaired macrophage recruitment and dysregulated type I interferon responses. We conclude that DOCK2 has an important role in the host immune response to SARS-CoV-2 infection and the development of severe COVID-19, and could be further explored as a potential biomarker and/or therapeutic target